2023 Fall Conference | C7 - New Therapies for Migraine and Other Headache Disorders

Date Friday 10/27/23

Time 01:00 PM - 02:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jessica Ailani, MD, FAAN

Topic(s) Headache

Learning Objectives Participants should become familiar with recent consensus and guidelines on new treatments in headache medicine, be able to discuss and review real-world use of new treatment options in headache medicine as well as real-world evidence of new treatment options in headache medicine, and be able to report about ongoing research in the field of headache medicine.

This program is supported in part by an educational grant from AbbVie.
The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.

CME Available 1.50 CME credits

Core Competencies Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Didactic, Audience Participation

Program Materials

Event Timeline
01:00 PM - 01:15 PM PDT	Introduction	Are We at a Consensus? Jessica Ailani, MD, FAAN
01:15 PM - 01:55 PM PDT	Speaker	Real World Evidence of New Migraine Therapies Zubair Ahmed, MD
01:55 PM - 02:20 PM PDT	Speaker	Top Evidence in Headache Over the Past Year Rebecca C. Burch, MD
02:20 PM - 02:30 PM PDT	Q&A	Ask the Questions, We Will Answer... Jessica Ailani, MD, FAAN, Rebecca C. Burch, MD, Zubair Ahmed, MD

Faculty Disclosures
Jessica Ailani, MD, FAAN	Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Rebecca C. Burch, MD	An immediate family member of Dr. Burch has received personal compensation for serving as an employee of Wellsky. Dr. Burch has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. An immediate family member of Dr. Burch has stock in Wellsky. Dr. Burch has received publishing royalties from a publication relating to health care.
Zubair Ahmed, MD	Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ahmed has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.

��ɫ��

��ɫ��